Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OCT are Expanding the Use of the CTMS Platform with Flex Databases

Published: Thursday, August 29, 2013
Last Updated: Thursday, August 29, 2013
Bookmark and Share
Expansion to implement the workflow management tool.

Flex Databases has announced that OCT are expanding the use of the Flex CTMS platform to implement the workflow management tool.

OCT is a full-service Contract Research Organization (CRO) founded in 2005 in St. Petersburg. OCT are operating in Russia, Ukraine, Belarus, Latvia, Lithuania, and Estonia.

"We have been working with Flex since March 2013", said Dmitry Sharov, President of OCT. "Offering a PSA platform rather than a stand-alone CTMS product, the Flex system has the tools to redefine what it means to be an efficient service organization. With every step we take, we can feel the technology lifting the weight off our shoulders. The workflow tool allows us to standardize every process, from a monitoring visit to hiring a new employee, while giving senior management full visibility on the status of each workflow."

"We are happy to see OCT leveraging the full potential of our platform", said Timur Galimov, Technical Director of Flex Databases. "Workflows are probably the most important tool in our toolbox. Imagine a virtual automated assembly line. This is what the workflow tool does for a process - once activated, it starts engaging people in the process, passing the task from one person to another, running checks and triggering alarm if something doesn't go as planned. Running a complex business process without a workflow tool is like building a car without an assembly line - it can be done, but it takes twice the time and costs twice the money."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flex Databases Launches New Web Site
New website cements the company's unique positioning as a PSA company.
Tuesday, March 25, 2014
Scientific News
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Study to Assess Shorter-Duration Antibiotics in Children
Physicians plan a clinical trial to evaluate whether short course anti-biotics are effective at treating CAP in children.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
Testing Zika Vaccine in Humans Begins
The first of five planned clinical trials to test ZPIV vaccine in humans has begun.
Combination Therapy Improved Chemoresistance in Ovarian Cancer
The study demonstrates how an existing class of targeted therapies could be used to potentiate the tumor suppression induced by cisplatin.
Gene Therapy for Blistering Skin Disease Shows Promise
Grafting genetically altered skin onto patients’ chronic wounds marks the first time skin-based gene therapy has been demonstrated to be safe and effective in humans.
Alzheimer’s Treatment Moves a Step Closer
Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!